Olatec Therapeutics
@olatecthera
Ph 2 clinical-stage pharma developing a new class of #NLRP3 therapeutics to treat & prevent a broad spectrum of acute & chronic inflammatory diseases
ID: 803979013437919232
http://www.olatec.com 30-11-2016 15:08:28
209 Tweet
246 Takipçi
1,1K Takip Edilen
Assessing the Ability of Dapansutrile, a Selective, Oral Inhibitor of the NLRP3 Neuroinflammatory Pathway, to Mitigate Progression of Parkinson’s Disease michaeljfox.org michaeljfox.org/grant/assessin… #Parkinsons #parkinsonsresearch